(HealthDay)—One year of adjuvant olaparib should be offered to patients with high-risk early-stage human epidermal growth factor receptor 2 (HER2)-negative breast cancer and germline BRCA
Read more
Home »
Research conducted at The Ohio State University Wexner Medical Center and College of Medicine’s School of Health & Rehabilitation Sciences found that federal autism research
Read more
(HealthDay)—In an American Academy of Pediatrics policy statement, published online July 20 in Pediatrics, updated recommendations are presented relating to use of barrier methods for
Read more
WEDNESDAY, Feb. 12, 2020 — In an American Academy of Neurology practice guideline, published online Feb. 12 in Neurology, recommendations are presented for addressing sleep
Read more